Key Takeaways
- Volume engine firing on all cylinders: Underlying volume growth hit 15.3% in Q4, with both consumer and B2B segments contributing strongly. Growth categories and core Fevicol both delivered double-digit expansion.
- Price hikes arrive as raw material cycle turns: Two staggered price increases taken in April and May, totaling ~12–15% for the Fevicol division, as management moves to pass on absolute rupee cost increases while keeping growth as the top priority.
- Margins expanded sharply, but the tailwind is reversing: EBITDA margin rose 280 bps on material benefits and operating leverage, but management warns FY27 will be different as input cost inflation returns and the 20–24% corridor becomes the relevant frame again.
- Export disruption and project waterproofing hit by external shocks: West Asia conflict disrupted March exports, while urban pollution restrictions stalled Nina Percept project sites in major cities. Both are temporary but highlight geographic and regulatory fragility.
- What to watch next quarter: Whether the two price hikes stick without meaningful volume backlash, how quickly West Asia supply chains normalize, and whether Q1 demand momentum holds if the conflict drags on.
Volume Growth & Demand Environment
- Broad-based volume acceleration: Q4 UVG of 15.3% was driven by C&B at 15.4% and B2B at 14.8%, with growth categories like Roff and Dr. Fixit performing at the higher end of their band and core Fevicol delivering double-digit growth. The portfolio fired uniformly across categories.
- FY26 stepped up vs FY25: UVG expanded by approximately 100–120 bps for the full year, a result management attributes to several quarters of reinvesting margin headroom behind demand generation and field marketing.
- Urban and rural both contributed: Rural growth came in ahead year-on-year, but urban growth also picked up meaningfully, creating the buoyancy management described.
- Policy tailwinds at work: Management pointed to GST 2.0 actions and budget announcements putting roughly INR 100,000 crores in the hands of taxpaying Indians as structural supports for discretionary category demand.
- Market share gains likely but unconfirmed: Pidilite believes it is growing ahead of the market in some growth and possibly core categories, driven by natural buoyancy plus intensified demand generation, but management said it is too early to comment on unorganized sector struggles or definitive share shifts.
- No channel loading: Pidilite followed its normal practice of slowing trade activity in the second half of March and accelerating in April, so the Q4 volume print does not reflect material trade stock build-up ahead of price hikes.
- Tile cluster disruption did not hit Roff: Despite gas shortages keeping Morbi tile cluster capacity utilization low, high tile inventory already in the dealer pipeline meant construction and tile fixing continued, insulating Roff demand in the quarter.
Vats: "I definitely believe that in the quarter that gone by Q1 calendar and Q4 financial I think there has been a buoyancy in urban demand."
Pricing & Raw Material Strategy
- Two rounds of price increases: A blended ~4–5% increase was taken in mid-April, followed by another ~7–8% blended increase in early May. For the Fevicol division specifically, the cumulative effect is approximately 12–15%, varying by product.
- Calibrated pass-through philosophy: Management's stated strategy is to pass on the absolute increase in raw material prices in rupee terms, done in a staggered fashion to avoid disrupting demand generation. Growth remains the overriding priority, with no short-termism on pricing.
- Inflation could reverse the approach: If raw material costs cool off quickly, management acknowledged some price increases may need to be passed back, making the full-year net realization uncertain.
- Supply security is manageable: A VAM supply source in Saudi Arabia was impacted by the West Asia conflict, but abundant global supply exists and Pidilite is exploring Chinese sources to ensure continuity. No availability concern.
- Demand compression expected but unquantified: Management expects some demand compression in FY27 from cumulative inflation across construction inputs like pipe, paints, cement, and fuel, but said the quantum and timing are difficult to predict. Q1 momentum may sustain, but the full year cannot be assumed to follow the same trajectory.
Vats: "Our strategy is that we will first pass on the absolute increase in our raw material prices in rupee terms in a calibrated fashion because our focus will remain growth and disciplined demand generation in the market."
Margin Performance & Outlook
- Q4 margin walk: EBITDA margin expanded 280 bps, with approximately 100 bps coming from gross margin improvement driven by material cost benefits and the balance from operating leverage as cost growth of 9.2% lagged sales growth of 15.3%.
- PAT growth lagged for technical reasons: Slower PAT growth relative to EBITDA was due to timing differences on dividends from subsidiaries, which were received in Q4 last year but not this year, and mark-to-market impact on treasury income from rising bond yields. Yields-to-maturity on all investments remain strong.
- Employee cost optics distorted: Standalone employee expense growth of 3% in Q4 is misleading. Last year's Q4 included a ~₹20 cr provision for a discretionary benefit; this year, that benefit was rolled back due to the new wage code elevating gratuity benefits, resulting in a ~₹20 cr reversal. Comparable growth is approximately 11.5%.
- FY27 margin frame shifts: Management reiterated the 20–24% EBITDA margin corridor, noting that last year's delivery at the higher end benefited from benign input costs. FY27 will be different due to raw material inflation, and the corridor is the relevant guide, not the FY26 exit.
Segment & Subsidiary Performance
| Segment | Trend | Commentary |
|---|---|---|
| Consumer & Bazaar | ▲ Strong | UVG of 15.4%; growth categories and core Fevicol both delivered double-digit growth. |
| B2B | ▲ Strong | UVG of 14.8%; broad-based industrial demand. |
| Dr. Fixit (retail waterproofing) | ▲ Recovered | Returned to growth-category levels, improving each quarter after earlier softness. |
| Nina Percept (project waterproofing) | ▼ Declined | Healthy order book but Q4 impacted by pollution restrictions halting construction sites in Delhi, Mumbai, Hyderabad. |
| International subsidiaries | ▬ Modest | Grew 8%; March exports disrupted by West Asia conflict after strong performance through February. |
| Domestic subsidiaries | ▲ Strong | Grew 5.3% overall, dragged by Nina's 16% decline; rest of domestic subsidiaries, largely C&B, recorded very strong growth and profitability. |
Strategic Initiatives & Capital Allocation
- BuildNext transferred to JSW One: Pidilite transferred its BuildNext Construction Solutions platform to JSW One in exchange for a small, insignificant shareholding in JSW One. Management described BuildNext as strategic for Pidilite but said JSW One was the right home to take it further. Exploration of other synergies, including potential marketplace participation, remains open-ended.
- Paints expansion still conditional: The rurban segment, covering rural and very small towns, is doing well and has expanded to West Bengal and Bihar. However, full-scale expansion into slightly bigger towns will happen only when Pidilite solves for its unique USP and right to win in those markets. Work on that business model continues.
- Capex stays within band: Capex will remain in the 3–5% of revenue range, directed at growth capacity, automation and consolidation, particularly in premium white glue, and newer categories. A large plant in West India for premium white glue and Fevicol will be commissioned in Q1 FY27.
- Demand generation investment continues: Pidilite ran a big above-the-line campaign for Fevicol during the quarter alongside below-the-line field marketing activities, consistent with its stated priority of driving volume growth over short-term margin optimization.
Vats: "I think once we are able to solve for that is when you will see a full-scale expansion... we will keep working towards finding that unique Pidilite signature and therefore, our right to win."
Demand Scenarios & External Risks
- Scenario one, conflict contained: If the West Asia conflict sees a pause or resolution in May, management expects demand buoyancy from Q4 FY26 to sustain and raw material inflation may cool in the second half.
- Scenario two, conflict persists: If the conflict continues longer, the focus shifts to supply security and scenario planning. Management will cross that bridge when it comes to it, with planning already underway.
- Dynamic environment limits visibility: Management emphasized the impossibility of providing a full-year view given the volatility, describing the operating environment as requiring week-by-week, month-by-quarter decision-making rather than multi-quarter commitments.
Vats: "So a week, month, quarter, again, a week, month, quarter, and that's the way you're going to decide here. Here, you cannot talk of 2 years full of this year because it's very, very dynamic my friend."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Volume growth ambition | Double-digit UVG, expanding ~100–120 bps per year | Ongoing annual target |
| EBITDA margin corridor | 20–24% | FY27 |
| Capex band | 3–5% of revenue | Ongoing |
| Price pass-through | Pass on absolute rupee increase in raw material costs in calibrated, staggered fashion | FY27, contingent on RM trajectory |
| Paints expansion | Full-scale expansion only after solving for unique USP in bigger small towns | No date (work in progress) |
| Premium white glue capacity | Large West India plant commissioning | Q1 FY27 |
Key Metrics
| Metric | Q4 FY26 |
|---|---|
| Standalone revenue | ₹3,272 cr, +15.3% YoY |
| Underlying volume growth (UVG) | 15.3%, vs 9.8% in 9M FY26 and 9.3% in FY25 |
| Consumer & Bazaar UVG | 15.4% |
| B2B UVG | 14.8% |
| Gross margin | +100 bps YoY, in line with Q3 FY26 |
| EBITDA margin | 23.4%, +280 bps YoY |
| EBITDA growth | 31.1% YoY |
| Consolidated revenue growth | 14.1% YoY |
| Consolidated EBITDA margin expansion | 310 bps YoY |
| Consolidated PAT growth | 36.6% YoY |
| Full-year consolidated revenue | ₹14,553 cr, +11.1% YoY |
| Full-year EBITDA margin expansion | 120 bps over FY25 |
| Full-year PAT growth | 17.9% YoY |
| Full-year UVG | 11.1%, ~100–120 bps above FY25 |
| International subsidiaries growth | 8% YoY |
| Domestic subsidiaries growth | 5.3% YoY; Nina waterproofing declined 16% due to environmental restrictions on work fronts |
| Capex | ~₹570 cr in FY26, vs ₹430 cr in FY25 |
| VAM price (Q4) | ~$840/tonne, in line with Q3 FY26 |
| Weighted average raw material basket inflation (current replacement cost) | 40% to 50% |
| Blended price increase taken | ~4%–5% in mid-April, another 7%–8% in early May |
| Fevicol division price increase | ~5% in April, 7%–9% in early May; total ~12%–15% |
| Final dividend per share | ₹11.5, plus special dividend of ₹5; payout ratio ~70% |